Clinical trial Recruiting at 2 sites Observational Ages 18 and up Women only

Rapid testing for bladder infections in women at general practices

Official title: Machbarkeit Und Explorative Validierung Des PA-100-AST-Systems Bei Frauen Mit Verdacht Auf Eine Unkomplizierte Harnwergsinfektion in Der Hausarztpraxis - Eine Pilotstudie

Run by Wuerzburg University Hospital · NCT06625268 · Data updated 2026-11-12

This study tests a quick urine test for bladder infections in women visiting their doctor to see if it can accurately diagnose the infection and help with treatment faster than traditional lab tests.

Quick facts

Study typeObservational
Ages18 Years and up
SexWomen only
Enrollment200 (estimated)
SponsorWuerzburg University Hospital
Academic / other
Locations2 sites (Würzburg, Bavaria and 1 other locations)
StatusRecruiting
StartedAugust 1, 2024
Main results expectedApril 30, 2025
Study endsApril 30, 2025
Registry record updatedFebruary 17, 2025
Trial IDNCT06625268 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adult, non-pregnant women aged 18 or older who exhibit symptoms of an uncomplicated urinary tract infection.

Probably not a fit

Patients with urinary catheters, severe urinary tract abnormalities, immunosuppression, or those unable to provide informed consent may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study involves adult women who visit their general practitioner with symptoms indicative of a bladder infection. Participants will provide a urine sample that will be tested using the PA-100-AST system, which quickly detects bacteria responsible for urinary tract infections and assesses antibiotic susceptibility. The results from this rapid test will be compared to traditional lab culture tests to evaluate its accuracy in a general practice setting. The aim is to determine if the PA-100-AST can effectively diagnose urinary tract infections and guide treatment in a timely manner.

Why it matters

Potential benefit: If successful, this study could lead to faster and more accurate diagnosis and treatment of urinary tract infections in women.

How similar studies have gone: While the PA-100-AST system has shown promise in preliminary evaluations, its effectiveness in a general practice setting has not yet been established, making this a novel approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Female sex
* Age 18 or older
* Clinically suspected UTI according to the general practitioner

Exclusion Criteria:

* Urinary catheter
* Severe urinary tract abnormality (such as cancer or strictures)
* Immunosuppression (such as chronic immunosuppressant use or AIDS)
* Dementia or any other condition (including insufficient knowledge of the German language) that could affect informed consent
* Known pregnancy

Where it's running

  • University Hospital Wurzburg, Department of General Practice
    Würzburg, Bavaria, Germany
    Recruiting
  • University Hospital Jena
    Jena, Thuringia, Germany
    Recruiting

Study contacts

  • Principal investigator: Ildikó Gágyor, MD,Professor — Wuerzburg University Hospital
  • Study coordinator: Peter K. Kurotschka, MD
  • Email: kurotschka_p@ukw.de
  • Phone: 0049017670882259

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.